Cooper Companies (COO) Issues FY 2019 Earnings Guidance

Cooper Companies (NYSE:COO) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided EPS guidance of $11.30-11.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.08. The company issued revenue guidance of $2.6-2.66 billion, compared to the consensus revenue estimate of $2.67 billion.Cooper Companies also updated its FY19 guidance to $11.30-11.70 EPS.

NYSE COO opened at $243.01 on Friday. The firm has a market capitalization of $13.61 billion, a P/E ratio of 21.13, a P/E/G ratio of 2.13 and a beta of 0.77. Cooper Companies has a twelve month low of $216.47 and a twelve month high of $283.18. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.58 and a quick ratio of 1.54.

Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, December 6th. The medical device company reported $2.87 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.96 by ($0.09). Cooper Companies had a return on equity of 17.86% and a net margin of 5.52%. The business had revenue of $651.50 million for the quarter, compared to analyst estimates of $645.25 million. During the same quarter in the previous year, the business posted $2.65 earnings per share. The business’s revenue was up 16.0% on a year-over-year basis. On average, sell-side analysts anticipate that Cooper Companies will post 12.1 EPS for the current fiscal year.

COO has been the subject of a number of recent analyst reports. Jefferies Financial Group increased their price target on Cooper Companies to $305.00 and gave the stock a buy rating in a report on Friday. ValuEngine upgraded Cooper Companies from a hold rating to a buy rating in a report on Thursday, September 27th. Oppenheimer set a $270.00 price target on Cooper Companies and gave the stock a hold rating in a report on Friday, August 31st. Zacks Investment Research downgraded Cooper Companies from a buy rating to a hold rating in a report on Thursday, August 16th. Finally, BMO Capital Markets increased their price target on Cooper Companies from $280.00 to $285.00 and gave the stock an outperform rating in a report on Friday, August 31st. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus target price of $284.50.

In other news, VP Randal Golden sold 1,731 shares of the firm’s stock in a transaction dated Thursday, September 27th. The stock was sold at an average price of $275.86, for a total value of $477,513.66. Following the completion of the sale, the vice president now directly owns 1,154 shares in the company, valued at approximately $318,342.44. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director A Thomas Bender sold 7,150 shares of the firm’s stock in a transaction dated Monday, September 24th. The shares were sold at an average price of $269.36, for a total value of $1,925,924.00. Following the completion of the sale, the director now owns 18,355 shares of the company’s stock, valued at $4,944,102.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 20,691 shares of company stock valued at $5,527,869. Company insiders own 1.60% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Cooper Companies (COO) Issues FY 2019 Earnings Guidance” was originally posted by WKRB News and is the sole property of of WKRB News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://www.wkrb13.com/2018/12/08/cooper-companies-coo-issues-fy-2019-earnings-guidance.html.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Article: How is an ETF different from a mutual fund?

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply